These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7189791)

  • 21. Combination chemotherapy with methotrexate (NSC-740), adriamycin (NSC-123127), cyclophosphamide (NSC-26271), and 5-fluorouracil (NSC19893) for adult solid tumors.
    Stephens RL; Hoogstraten B
    Cancer Chemother Rep; 1974; 58(6):943-5. PubMed ID: 4614901
    [No Abstract]   [Full Text] [Related]  

  • 22. [Chemotherapic management of genitomammary tumors].
    Sarría JA; Irigoyen ML; Cismondi B
    Rev Fac Cien Med Univ Nac Cordoba; 1981; 39(1-4):3-16. PubMed ID: 6897122
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of chemotherapeutic responsiveness in Nb rat prostate cancer model. 5-fluorouracil, methotrexate, cyclophosphamide, and adriamycin.
    Drago JR; Goldman L; Gershwin ME
    Invest Urol; 1980 Jul; 18(1):80-1. PubMed ID: 7410017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapy in the treatment strategy of breast cancer.
    Carbone PP
    Cancer; 1975 Aug; 36(2):633-7. PubMed ID: 1157025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapy principles in the treatment of prostatic cancer.
    Könyves I; Müntzing J; Rozencweig M
    Prostate; 1984; 5(1):55-62. PubMed ID: 6364076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined therapy of advanced prostatic carcinoma with estramustine and prednimustine.
    Catane R; Kaufman J; Mittelman A; Murphy GP
    J Urol; 1977 Mar; 117(3):332-5. PubMed ID: 839597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemotherapy of breast cancer.
    Mitchell MS
    Conn Med; 1975 Jan; 39(1):4-5. PubMed ID: 1109851
    [No Abstract]   [Full Text] [Related]  

  • 28. Moderately high-dosage methotrexate medication in metastatic breast cancer.
    Wils JA
    Neth J Med; 1980; 23(2):59-61. PubMed ID: 7374869
    [No Abstract]   [Full Text] [Related]  

  • 29. Cyclophosphamide, methotrexate and 5-fluorouracil combination chemotherapy versus chloroethyl-cyclohexy-nitrosourea in the treatment of metastatic prostatic cancer.
    Herr HW
    J Urol; 1982 Mar; 127(3):462-5. PubMed ID: 7062419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prednimustine for prostate cancer therapy.
    Slack NH; Murphy GP
    Compr Ther; 1979 Sep; 5(9):54-7. PubMed ID: 487742
    [No Abstract]   [Full Text] [Related]  

  • 31. [Role and limitations of chemotherapy in breast cancer].
    Cattan A; Pourny C
    Sem Hop; 1975 Jul 10-20; 51(31-34):2119-21. PubMed ID: 170687
    [No Abstract]   [Full Text] [Related]  

  • 32. The use of estramustine and prednimustine versus prednimustine alone in advanced metastatic prostatic cancer patients who have received prior irradiation.
    Murphy GP; Gibbons RP; Johnson DE; Prout GR; Schmidt JD; Soloway MS; Loening SA; Chu TM; Gaeta JF; Saroff J; Wajsman Z; Slack N; Scott WW
    Trans Am Assoc Genitourin Surg; 1978; 70():69-71. PubMed ID: 753026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple drug chemotherapy regimen for patients with hormonally-unresponsive carcinoma of the prostate: a preliminary report.
    Kane RD; Stocks LH; Paulson DF
    J Urol; 1977 Apr; 117(4):467-71. PubMed ID: 850320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Castration--chemotherapy treatment of prostate cancer model.
    Drago JR; Worgul TJ; Gallagher C
    J Surg Res; 1981 Apr; 30(4):338-42. PubMed ID: 7194949
    [No Abstract]   [Full Text] [Related]  

  • 35. New steroidal alkylating agents in advanced stage D carcinoma of the prostate.
    Mittelman A; Catane R; Murphy GP
    Cancer Treat Rep; 1977; 61(2):307-10. PubMed ID: 872134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of estramustine and prednimustine versus prednimustine alone in advanced metastatic prostatic cancer patients who have received prior irradiation.
    Murphy GP; Gibbons RP; Johnson DE; Prout GR; Schmidt JD; Soloway MS; Loening SA; Chu TM; Gaeta JF; Saroff J; Wajsman Z; Slack N; Scott WW
    J Urol; 1979 Jun; 121(6):763-5. PubMed ID: 458947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Future implications of phase 2 chemotherapy trials in ninety-five patients with measurable advanced bladder cancer.
    Yagoda A
    Cancer Res; 1977 Aug; 37(8 Pt 2):2775-80. PubMed ID: 68814
    [No Abstract]   [Full Text] [Related]  

  • 38. Chemotherapy of advanced carcinoma of the prostate with 5-fluorouracil, cyclophosphamide and adriamycin.
    Merrin C; Etra W; Wajsman Z; Baumgartner G; Murphy G
    J Urol; 1976 Jan; 115(1):86-8. PubMed ID: 1107604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adriamycin (NSC-123127) versus 5-fluorouracil (NSC-19893) and cyclophosphamide (NSC-26271) in the treatment of metastatic prostate cancer.
    Eagan RT; Hahn RG; Myers RP
    Cancer Treat Rep; 1976 Jan; 60(1):115-7. PubMed ID: 1000515
    [No Abstract]   [Full Text] [Related]  

  • 40. A pilot study of sequential combination chemotherapy with adriamycin and cyclophosphamide, and methotrexate, 5-fluorouracil and prednisolone in advanced breast cancer.
    Collis CH
    Br J Clin Pract; 1978 May; 32(5):139-44. PubMed ID: 666968
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.